Early Adult Risk Factor Levels and Subsequent Coronary Artery Calcification The CARDIA Study by Loria, Catherine M. et al.
F
l
d
A
p
F
a
N
o
B
o
O
P
U
C
I
2
Journal of the American College of Cardiology Vol. 49, No. 20, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PEarly Adult Risk Factor Levels and
Subsequent Coronary Artery Calcification
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Objectives We sought to determine whether early adult levels of cardiovascular risk factors predict subsequent coronary
artery calcium (CAC) better than concurrent or average 15-year levels and independent of a 15-year change in
levels.
Background Few studies have used multiple measures over the course of time to predict subclinical atherosclerosis.
Methods African American and white adults, ages 18 to 30 years, in 4 U.S. cities were enrolled in the prospective CARDIA
(Coronary Artery Risk Development in Young Adults) study from 1985 to 1986. Risk factors were measured at
years 0, 2, 5, 7, 10, and 15, and CAC was assessed at year 15 (n  3,043).
Results Overall, 9.6% adults had any CAC, with a greater prevalence among men than women (15.0% vs. 5.1%), white
than African American men (17.6% vs. 11.3%), and ages 40 to 45 years than 33 to 39 years (13.3% vs. 5.5%).
Baseline levels predicted CAC presence (C  0.79) equally as well as average 15-year levels (C  0.79; p 
0.8262) and better than concurrent levels (C  0.77; p  0.019), despite a 15-year change in risk factor levels.
Multivariate-adjusted odds ratios of having CAC by ages 33 to 45 years were 1.5 (95% confidence interval [CI]
1.3 to 1.7) per 10 cigarettes, 1.5 (95% CI 1.3 to 1.8) per 30 mg/dl low-density lipoprotein cholesterol, 1.3 (95%
CI 1.1 to 1.5) per 10 mm Hg systolic blood pressure, and 1.2 (95% CI 1.1 to 1.4) per 15 mg/dl glucose at base-
line. Young adults with above optimal risk factor levels at baseline were 2 to 3 times as likely to have CAC.
Conclusions Early adult levels of modifiable risk factors, albeit low, were equally or more informative about odds of CAC
in middle age than subsequent levels. Earlier risk assessment and efforts to achieve and maintain optimal
risk factor levels may be needed. (J Am Coll Cardiol 2007;49:2013–20) © 2007 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.009r
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mewer young adults report being screened for serum cho-
esterol than older adults (1), possibly because cardiovascular
isease (CVD) risk factor levels are generally low at this age.
common approach is to wait until risk factors develop to
rescribe lifestyle changes or pharmacological treatment,
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nd Blood Institute, Bethesda, Maryland; †Department of Preventive Medicine,
orthwestern University, Feinberg School of Medicine, Chicago, Illinois; ‡Division
f Preventive Medicine, School of Medicine, University of Alabama at Birmingham,
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akland, California; Division of Epidemiology and Community Health, School of
ublic Health, University of Minnesota, Minneapolis, Minnesota; and **Harbor-
niversity of California Los Angeles Research and Education Institute, Torrance,
alifornia. The CARDIA study is supported by the National Heart, Lung, and Blood
nstitute (N01-HC-95095, N01-HC-48047-48050, and N01-HC-05187).e
Manuscript received September 25, 2006; revised manuscript received January 19,
007, accepted January 22, 2007.ather than prevent or delay the onset of risk factors. Yet,
oung adults from a large autopsy study already had ath-
rosclerotic lesions, and the extent of lesions was associated
ith risk factor levels (2). Thus, higher risk factor levels,
espite being relatively low, may identify young adults more
ikely to develop early atherosclerosis. If early adult levels
redict CVD risk as well as levels measured in middle age,
ugmented efforts to encourage young adults to achieve and
aintain optimal risk factor levels might lead to more adults
eaching middle age at low risk for CVD. A low-risk status
n middle age has been linked to lower CVD morbidity and
ortality, lower health care costs, increased life expectancy,
nd higher self-reported quality of life (3–7).
Few studies have followed younger adults to assess later
orbidity and mortality, but all of the studies concur thatstablished risk factors early in adulthood, such as serum total
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Early Adult Risk Factors and Coronary Calcium May 22, 2007:2013–20cholesterol (8,9), blood pressure
(10,11), and cigarette smoking
(12), predict subsequent CVD.
However, none of these studies
examined multiple measures
throughout young adulthood to
assess whether subsequent risk
was predicted better by earlier
compared with later levels. Fur-
ther, none of these cohorts as-
sessed the relation of risk factors
to subclinical disease. Only a few
studies with recently established
cohorts have examined whether
early adult risk factor levels are as
informative of later subclinical
disease risk as risk factors mea-
ured later in life, when levels generally are higher (13,14).
hese studies tend to be small or have little or no ethnic
iversity, which limits their generalizability.
We used data from the CARDIA (Coronary Artery Risk
evelopment in Young Adults) study, a large, biracial,
rospective cohort study, to determine whether established,
odifiable CVD risk factors measured in adults ages 18 to
0 years predicted the presence of coronary artery calcium
CAC) at ages 33 to 45 years as well as levels of these same
isk factors measured concurrently with CAC. We also
ssessed how well long-term exposure, using average levels
easured several times over 15 years, predicted CAC.
oronary artery calcium is correlated with histological
laque area (15), and the extent of CAC predicts coronary
eart disease events in asymptomatic adults (16–21). Pre-
ious studies found that CAC is greater among whites than
frican Americans and greater among men than women
nd that prevalence increases with age (13,22–29). Accord-
ngly, we report CAC prevalence among 33- to 45-year-old
frican American and white adults and test differences by
ace, gender, and age.
ethods
ARDIA is a multicenter study of the development and
eterminants of CVD risk factors in young adults initially
ges 18 to 30 years. The study design has been published
lsewhere in detail (30). In brief, 5,115 African American
nd white participants were recruited at baseline from 1985
o 1986 in 4 U.S. cities (Birmingham, Alabama; Chicago,
llinois; Minneapolis, Minnesota; and Oakland, California)
ith population-based samples approximately balanced
ithin center by gender, age, race, and education.
ollow-up examinations were completed at years 2, 5, 7, 10,
nd 15 with 90%, 86%, 81%, 79%, and 74%, respectively, of
he surviving cohort returning. Each examination protocol
as approved by institutional review boards at each site, and
Abbreviations
and Acronyms
BMI  body mass index
BP  blood pressure
CAC  coronary artery
calcium
CI  confidence interval
CT  computed tomography
CVD  cardiovascular
disease
HDL-C  high-density
lipoprotein cholesterol
LDL-C  low-density
lipoprotein cholesterol
OR  odds rationformed consent was obtained at every examination. fssessment of risk factors. A common protocol and
uality control procedures were used at all examinations.
articipants were asked to fast for 12 h and to avoid
moking and heavy physical activity for 2 h before their
xamination. Age, gender, and smoking habits were ascer-
ained through questionnaires. Three seated blood pressure
BP) measurements were obtained with a random-zero
phygmomanometer; the mean of the second and third
eadings was used for this report. Plasma total cholesterol,
igh-density lipoprotein cholesterol (HDL-C), and triglyc-
rides were determined using an enzymatic assay by North-
est Lipids Research Laboratory (Seattle, Washington) at
ll time periods; reanalysis at each examination of stored
amples from the previous examination indicates that mea-
ures over the course of time were comparable. Low-density
ipoprotein cholesterol (LDL-C) was derived by the Friede-
ald equation (31). Serum glucose was measured at year 0
sing the hexokinase ultraviolet method by American Bio-
cience Laboratories (Van Nuys, California), and at years 7,
0, and 15 using hexokinase coupled to glucose-6-
hosphate dehydrogenase by Linco Research (St. Louis,
issouri). Body weight was measured with light clothing to
he nearest 0.2 lb, body height without shoes was measured
o the nearest 0.5 cm, and body mass index (BMI) was
alculated from these measures (kg/m2).
ssessment of CAC. Two computed tomography (CT)
cans were obtained at year 15 for each participant using
lectron beam CT (Imatron C-150, GE Medical Systems,
ilwaukee, Wisconsin [Chicago and Oakland centers]) or
ultidetector CT scanners (GE Lightspeed, GE Medical
ystems [Birmingham center] or Volume Zoom, Siemans,
rlangen, Germany [Minneapolis center]) (32). For each
can, 40 consecutive images from the root of the aorta to the
pex of the heart were obtained. Participants remained
upine between scans taken 1 to 2 min apart.
Scans were read centrally by a trained reader who exam-
ned each participant’s scan independently of the other. The
eader identified a region of interest for each potential focus
f CAC, defined as 4 or more adjacent pixels (1.87 mm2)
ith a CT number 130 HU (field of view  35 cm).
gatston scores (33) were adjusted for between-center
ifferences using a standard calcium phantom scanned
nderneath each participant (32), and summed across the 4
ajor coronary arteries to compute a total calcium score.
he presence of CAC was defined as having a positive,
on-zero Agatston score, using the average of 2 scans.
iven the young age of the subjects, each scan set with at
east one non-zero score (n  350, 11.5%) was reviewed by
n expert investigator (R.D.), who was blinded to the scan
cores to verify CAC presence. The agreement between scans
as reasonable (kappa  0.79, 95% confidence interval [CI]
.75 to 0.83), with only 3.6% discordant.
xclusions. Participants who completed the year 15 exam-
nation (n  3,672) were excluded from analyses if they
ere missing data on CAC (n  629) or additionally riskactors at year 0 (n  287) or year 15 (n  322). Complete
r
p
e
t
o
g
t
1
l
8
l
t
o
y
S
e
t
S
c
U
C
b
1
u
f
5
7
e
a
m
t
a
A
f
a
c
C
s
i
g
(
d
(
s
i
w
p
p
b
c
I
R
O
d
p
w
s
C
y
o
o
c
(
a
l
o
o
p
B
s
w
m
c
a
g
p
d
n
y
a
m
H
a
Pi
*
m
2015JACC Vol. 49, No. 20, 2007 Loria et al.
May 22, 2007:2013–20 Early Adult Risk Factors and Coronary Calciumisk factor and CAC data were available for 2,433 partici-
ants from both examinations and 2,756 from the baseline
xamination. Participants who returned compared with
hose who did not return to the year 15 examination were
lder and at baseline smoked fewer cigarettes and had
reater total and LDL cholesterol (data not shown). Par-
icipants were ineligible for CT scanning if pregnant (n 
8 tested positive in clinic) or if weight was above scanner
imits (n 44). Participants who had a CT scan (n 3,043;
3% of year 15 participants) were older, had greater LDL-C
evels but smoked fewer cigarettes, and had lower BMI values
han those not scanned (data not shown). Compared with
ther race-gender groups, more white men who returned at
ear 15 had a CT scan (88.6% vs. 78.3% to 83.4%).
tatistical analyses. Baseline characteristics by CAC pres-
nce were computed as means or percents and differences
ested using t tests or chi-square statistics, respectively.
pearman correlation coefficients were used to assess asso-
iations between baseline and year 15 risk factor levels.
sing logistic regression, odds ratios (ORs) and 95% CIs of
AC were estimated for continuous risk factor levels at: 1)
aseline (year 0); 2) year 15; and 3) averaged during the
5-year period. Average risk factor levels were calculated
sing all nonmissing data from years 0, 2, 5, 7, 10, and 15
or cigarettes smoked, systolic BP, and BMI; from years 0,
, 7, 10, and 15 for LDL-C and HDL-C; and from years 0,
, 10, and 15 for glucose. Each of the 3 risk factor sets was
xamined using minimally adjusted models, which included
ge, race, gender, and field site, and multivariate-adjusted
odels, which additionally included all risk factors within
he set. For each risk factor, ORs were calculated per
pproximate SD units at baseline to facilitate comparisons.
ll baseline and 15-year change (year 15  year 0) in risk
actor levels were entered simultaneously into a model
djusted also for age, race, gender, and site. Models were
ompared using a nonparametric test of correlated
-statistics, which are summary measures of each model’s
ensitivity and specificity (34). A fifth model used variables
ndicating whether each continuous, baseline risk factor was
reater than (or less than for HDL-C) optimal levels
LDL-C 130 mg/dl, HDL-C 40 mg/dl, systolic/
iastolic BP 120/80 mm Hg, glucose 110 mg/dl)
35,36). Variables indicating field site were not statistically
ignificant (at p  0.05) in any model and are not presented
n the tables. Finally, to assess effects of nonresponse bias,
e used a response propensity approach, which used the
robability of having a CT examination based on all 5,115
articipants as weights to compute point estimates, and
ootstrap methods to calculate 95% CI. All analyses were
onducted with SAS versions 8.02 and 9.1 (SAS Institute
nc., Cary, North Carolina).
esults
f the 3,043 participants with a CT scan, 258 or 9.6% had
etectable CAC at year 15 (Table 1). CAC was more (revalent among men than women (15.0% vs. 5.1%) and
hite than African-American men (17.6% vs. 11.3%) but
imilar among African-American and white women (5%).
AC was twice as prevalent among adults ages 40 to 45
ears than 33 to 39 years (13.3% vs. 5.5%). Approximately
ne-half of non-zero Agatston scores were 20, with
ne-half 20 (Table 1).
Very few participants at baseline had high levels of total
holesterol (4%,200 mg/dl), LDL-C (6%,130 mg/dl), BP
2%,120/80 mm Hg), or serum glucose (1%,110 mg/dl)
ccording to clinical guidelines, although 11% had a HDL-C
evel 40 mg/dl. In contrast, more than 20% had above
ptimal levels of LDL-C or BP, 34% were overweight or
bese, and 25% smoked cigarettes (Fig. 1). By year 15, more
articipants had above-optimal levels of LDL-C (30%) and
P (35%), whereas 67% were overweight or obese, but fewer
moked cigarettes (19%) (Fig. 1). Participants with versus
ithout CAC were older and at both years 0 and 15 smoked
ore cigarettes, had lower HDL-C, and had greater total
holesterol, LDL-C, triglycerides, systolic and diastolic BP,
nd glucose levels (Table 2). Participants with CAC had
reater BMI values at year 0 but not at year 15. Few, if any,
articipants reported taking medications for hypertension or
iabetes at baseline (0.05%); lipid-lowering drug use was
ot collected but is presumed low too. Medication use at
ear 15 was still infrequent for lipids (2%), diabetes (2%),
nd BP (8%). Baseline and year 15 levels were correlated for
ost risk factors (r  0.8 for BMI; r  0.6 for LDL-C,
DL-C, smoking; r  0.5 for systolic BP; p  0.001),
lthough less so for systolic BP among men and for glucose
revalence of CAC at Year 15n the CARDIA Study, 2000 to 2001
Table 1 Prevalence of CAC at Year 15in the CARDIA Study, 2000 to 2001
n % p Value
Any CAC
Overall 3,043 9.6
Race-gender group 0.0001
African-American women* 800 4.9
African-American men† 576 11.3
White women* 860 5.2
White men† 807 17.6
Gender 0.0001
Men 1,383 15.0
Women 1,660 5.1
Age 0.0001
33 to 39 yrs 1,464 5.5
40 to 45 yrs 1,579 13.3
Agatston score
0–10 95 3.1
10–20 46 1.5
20–100 102 3.3
100–400 40 1.3
400 8 0.3
p  0.76, African-American versus white women. †p  0.001, African-American versus white
en.
CAC  coronary artery calcium.r  0.3, p  0.001).
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Early Adult Risk Factors and Coronary Calcium May 22, 2007:2013–20At baseline, more cigarettes smoked per day in addition
o greater levels of LDL-C, systolic BP, and glucose were
ssociated with having CAC 15 years later, after adjustment for
ach other, BMI, HDL-C, race, gender, and age (Table 3). In
eparate models adjusted for race, gender, and age, BMI
OR 1.28; 95% CI 1.10 to 1.49 per 5 kg/m2) and HDL-C
OR 0.80; 95% CI 0.70 to 0.90 per 10 mg/dl) were
ssociated with CAC, even though they were not associated
ndependently of other risk factors. Year 15 levels of
DL-C, systolic BP, and smoking were correlates of CAC
n multivariate-adjusted models, with OR of similar magni-
ude, direction, and significance to baseline models (Table 3).
ody mass index, HDL-C, and glucose level were not
ross-sectional correlates independently of other risk factors,
lthough glucose was associated with CAC in minimally
Figure 1 Percent of Participants With Above Optimal Levels of
to Clinical Guidelines and Who Smoked Cigarettes at
Above optimal defined as: low-density lipoprotein (LDL) cholesterol 130 mg/dl; h
cholesterol 40 mg/dl; systolic/diastolic blood pressure 120/80 mm Hg; gluco
Baseline and Year 15 Characteristics (Mean orby CAC Status at Ages 33 to 45 Years in the C
Table 2 Baseline and Year 15 Characteristiby CAC Status at Ages 33 to 45 Ye
Year 0
No CAC
Mean (SD), %
With CAC
Mean (SD),
n 2,202 231
Male gender, % 41.9 71.0
White race, % 55.9 66.2
Age, yrs 25.0 (3.6) 27.0 (3.0)
Current smoker, % 23.2 38.2
Cigarettes/day 3.1 (7.2) 6.6 (11.2
Total cholesterol, mg/dl 176.4 (31.9) 191.6 (36.3
LDL-C, mg/dl 108.7 (29.8) 125.4 (33.8
HDL-C, mg/dl 53.8 (12.9) 48.8 (12.6
Triglycerides, mg/dl 69.3 (42.1) 87.6 (50.0
SBP, mm Hg 109.6 (10.4) 115 (11.7
DBP, mm Hg 68.2 (9.2) 72 (10.1
BMI, kg/m2 24.2 (4.6) 25.3 (4.8)
Glucose, mg/dl 81.6 (9.4) 87 (30.3BMI  body mass index; CAC  coronary artery calcium; DBP  diastolic bl
low-density lipoprotein cholesterol; SBP  systolic blood pressure.djusted models (OR 1.11; 95% CI 1.02 to 1.22 per 15
g/dl). Using average 15-year levels in multivariate-
djusted models, the same risk factors as in baseline models
ere associated with CAC at year 15, although the OR was
ower for number of cigarettes and higher for systolic BP
Table 3). The C-statistic was larger for models containing
aseline versus year 15 risk factor levels (0.79 vs. 0.77; p 
.019) but the same for models containing risk factors at
aseline versus 15-year averages (0.79 vs. 0.79; p 0.8262).
n sensitivity analyses with CAC presence defined as an
gatston score 15, nearly identical ORs remained statis-
ically significant, except for race and 15-year average
lucose level (data not shown). C-statistics were greater
han models using an Agatston score 0 for year 0 (C 
.82; 95% CI 0.79 to 0.85) and 15-year average levels (C 
iovascular Disease Risk Factors According
s 0 and 15 in the CARDIA Study, 1985 to 1986
nsity lipoprotein (HDL)
10 mg/dl; body mass index 25 kg/m2.
ent)A Study
ean or Percent)
n the CARDIA Study
Year 15
p Value
No CAC
Mean (SD), %
With CAC
Mean (SD), % p Value
2,202 231
0.001 — —
0.002 — —
0.001 40.1 (3.6) 42.0 (3.0) 0.001
0.001 17.8 30.7 0.001
0.001 2.2 (6.3) 4.2 (8.1) 0.001
0.001 183.4 (32.6) 198.0 (40.7) 0.001
0.001 112.5 (30.1) 126.3 (38.8) 0.001
0.001 51.1 (14.3) 46.6 (14.6) 0.001
0.001 97.2 (58.5) 123.3 (71.2) 0.001
0.001 112.3 (14.1) 119.6 (17.4) 0.001
0.001 74 (11.1) 78.7 (13.0) 0.001
0.001 28.4 (6.3) 28.7 (5.8) 0.500
0.007 85.3 (17.8) 90.6 (22.6) 0.001Card
Year
igh-de
se 1PercARDI
cs (M
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%
)
)
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)
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)
)ood pressure; HDL-C  high-density lipoprotein cholesterol; LDL-C 
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May 22, 2007:2013–20 Early Adult Risk Factors and Coronary Calcium.81; 95% CI 0.77 to 0.84), but comparisons among
-statistics remained the same. Analyses to assess the effects
f nonresponse bias yielded similar results to those pre-
ented based on only the 2,433 participants who returned
nd had a CT scan at year 15 (data not shown).
In a model including baseline and 15-year changes in
evels, ORs for baseline levels were of similar magnitude and
ignificance as in models with baseline levels alone, although
ystolic BP was only borderline significant (Table 4, Model 1).
n contrast, systolic BP was the only risk factor for which
5-year change was a significant CAC predictor. The
-statistic for this model (C  0.80; 95% CI 0.77 to 0.83)
as greater than for models containing year 0 (p  0.03) or
ear 15 (p  0.0004) risk factors alone but the same as the
verage 15-year model (p  0.12). Results were similar
hen adjusted for self-reported use of BP, lipids, or diabetes
edications at year 15 (Table 4, Model 2), although
aseline systolic BP was no longer borderline significant. In
ensitivity analyses redefining CAC presence as an Agatston
core 15, baseline systolic BP was significant but 15-year
hange in systolic BP and race were no longer significant
hile other results did not change (data not shown). The
-statistic for this model (C  0.83; 95% CI 0.80 to 0.86)
as no longer significantly different from the year 0 model.
The OR for having CAC was significant for each afore-
entioned risk factor compared with below-optimal levels at
aseline in minimally adjusted models (Table 5). In the
ultivariate-adjusted model, ORs of having CAC were 2-fold
reater for smokers and participants with above-optimal
DL-C, and 3 times greater for above-optimal glucose levels.
BMI25 kg/m2 and elevated BP ( 120/80 mm Hg) were
ssociated with a 1.5 to 2 times greater risk.
iscussion
s expected, few young adults in the CARDIA study had
ORs for Having CAC at Year 15 by CardiovasculModels* Us Levels at Year 0, Year 15, nd tCARDIA Study (n  2,433)
Table 3
ORs for Having CAC at Year 15 by
Models* Using Levels at Year 0, Ye
CARDIA Study (n  2,433)
Risk Factors
Year 0
OR 95% CI
Age, 5 yrs 2.31 (1.80–2.96)
White race 1.41 (1.02–1.95)
Male gender 2.42 (1.71–3.40)
Cigarettes/day, 10 1.46 (1.26–1.68)
LDL-C, 30 mg/dl 1.52 (1.33–1.75)
SBP, 10 mm Hg 1.29 (1.12–1.50)
BMI, 5 kg/m2 1.03 (0.87–1.24)
HDL-C, 10 mg/dl 0.90 (0.78–1.02)
Glucose, 15 mg/dl 1.19 (1.04–1.36)
C-statistic (95% CI) 0.79 (0.76–0.82)
*Simultaneously adjusted for age, race, gender, site, and all other risk
exams (i.e., years 0, 2, 5, 7, 10, and 15 for cigarettes smoked, SBP, B
fasting glucose). Odds ratios (ORs) were calculated per approximate S
CI  confidence interval; other abbreviations as in Table 2.igh levels of established CVD risk factors at baseline using
yhresholds set for older adults. Yet, the relatively low levels
t ages 18 to 30 years predicted CAC presence by ages 33 to
5 years as well as average levels during the 15-year period,
nd better than more adverse risk factor levels measured at
ges 33 to 45 years. Baseline levels predicted CAC regard-
ess of 15-year change in levels, but 15-year changes in levels
sk Factors in 3 Multivariateerage Over 15 Years† From the
ovascular Risk Factors in 3 Multivariate
, and the Average Over 15 Years† From the
Year 15 Average Years 0 to 15†
R 95% CI OR 95% CI
6 (1.82–2.94) 2.32 (1.81–2.96)
9 (1.07–2.06) 1.49 (1.07–2.08)
9 (1.87–3.67) 1.95 (1.37–2.77)
5 (1.05–1.48) 1.35 (1.16–1.59)
8 (1.12–1.47) 1.54 (1.32–1.80)
9 (1.17–1.42) 1.60 (1.36–1.88)
2 (0.80–1.07) 0.88 (0.74–1.04)
5 (0.82–1.04) 0.88 (0.76–1.02)
6 (0.96–1.17) 1.17 (1.02–1.35)
7 (0.74–0.80) 0.79 (0.76–0.82)
s listed in Table 3. †Average of nonmissing risk factor levels from all
rs 0, 5, 7, 10, and 15 for LDL-C and HDL-C; years 0, 7, 10, and 15 for
at baseline.
Rs for Having CAC at Year 15 by Cardiovascularisk Factors in Multivariate Models* Includinga eline nd 15-Year Ch nge in Levels (Model 1)nd Adjusting for Medication Use at Year 15 (Model) in th CARDIA S udy (n  2,433)
Table 4
ORs for Having CAC at Year 15 by Cardiovascular
Risk Factors in Multivariate Models* Including
Baseline and 15-Year Change in Levels (Model 1)
and Adjusting for Medication Use at Year 15
(Model 2) in the CARDIA Study (n  2,433)
Model 1 Model 2
OR 95% CI OR 95% CI
Age, 5 yrs 2.20 (1.72–2.83) 2.15 (1.67–2.76)
White race 1.50 (1.07–2.11) 1.57 (1.11–2.21)
Male gender 2.38 (1.66–3.42) 2.47 (1.71–3.58)
Year 0 level
Cigarettes/day, 10 1.41 (1.19–1.67) 1.41 (1.19–1.67)
LDL-C, 30 mg/dl 1.43 (1.20–1.71) 1.42 (1.18–1.72)
SBP, 10 mm Hg 1.16 (1.00–1.37) 1.13 (0.96–1.33)
BMI, 5 kg/m2 1.21 (0.91–1.62) 1.24 (0.92–1.66)
HDL-C, 10 mg/dl 0.89 (0.74–1.04) 0.89 (0.75–1.05)
Glucose, 15 mg/dl 1.18 (1.03–1.35) 1.17 (1.02–1.35)
15-yr change† in level
Cigarettes/day, 10 1.01 (0.82–1.25) 1.02 (0.83–1.30)
LDL-C, 30 mg/dl 1.08 (0.91–1.28) 1.09 (0.91–1.30)
SBP, 10 mm Hg 1.20 (1.08–1.34) 1.19 (1.07–1.33)
BMI, 5 kg/m2 0.82 (0.64–1.03) 0.80 (0.64–1.01)
HDL-C, 10 mg/dl 1.01 (0.86–1.18) 1.01 (0.86–1.18)
Glucose, 15 mg/dl 1.00 (0.88–1.12) 0.99 (0.87–1.14)
Medication use at year 15
Blood pressure 1.59 (0.95–2.69
Lipids 0.95 (0.44–2.06)
Diabetes 0.81 (0.26–2.48)
Simultaneously adjusted for all variables listed in each model. †Calculated as year 15 ar Rihe Av
Cardi
ar 15
O
2.3
1.4
2.6
1.2
1.2
1.2
0.9
0.8
1.0
0.7
factor
MI; yeaear 0.
Abbreviations as in Tables 2 and 3.
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he only exception was 15-year change in systolic BP,
uggesting it provides additional information to baseline
ystolic BP about the odds of having CAC. Nevertheless,
ur data strongly indicate that early adult levels of modifi-
ble risk factors predicted subsequent CAC. Moreover,
oung adults with above- versus below-optimal levels at
aseline were 2 to 3 times as likely to have CAC. Coronary
rtery calcium was more prevalent in older versus younger
articipants, suggesting that plaque calcification may begin
o accelerate by ages 40 to 45 years. Thus, greater efforts
imed at achieving and maintaining optimal risk factor
evels as early as possible may be warranted to prevent or
elay calcification of arterial plaque.
The prevalence of CAC in adults in the CARDIA study
as similar among 39- to 45-year-old Army personnel
22,23) but lower than in 3 studies with comparable ages
13,37,38). Discrepancies with the latter studies may be
xplained by their small sample size (13,38), little ethnic
iversity (13,38), and nonrepresentative samples of self-
eferred or physician-referred volunteers (37,38). Also, re-
earchers in the CARDIA study used a larger minimum
rea threshold to identify calcified lesions (1.87 mm2 vs.
.51 to 1.03 mm2) and 2 CT scans to reduce variability,
hich could explain differences with the latter 3 studies,
specially in young populations (39,40). Year 15 CAC
revalence was lower than previously published estimates
rom a CARDIA pilot of 427 participants at year 10 (14),
sing a different CT reading center, protocol, and software
han at year 15. When the year 10 scans were reread using
dentical methods by the year 15 reading center, CAC
revalence was greater at year 15 than at year 10 (11.7% and
.5% in white and African-American men, 2.3% and 2.4%
Rs for Having CAC at Year 15 by Age, Race,ender, and Presence of Above* Optimal Levels ofardi vascula Disease Risk Factors at B s line inhe CARDIA Study (n  2,756)
Table 5
ORs for Having CAC at Year 15 by Age, Race,
Gender, and Presence of Above* Optimal Levels of
Cardiovascular Disease Risk Factors at Baseline in
the CARDIA Study (n  2,756)
Minimally Adjusted†
Multivariate
Adjusted‡
Year 0 Risk Factors OR 95% CI OR 95% CI
Age, 5 yr 2.54 (2.03–3.18) 2.44 (1.93–3.08)
White race 1.32 (0.99–1.75) 1.62 (1.20–2.19)
Male gender 3.35 (2.52–4.46) 2.93 (2.16–3.97)
Current smoker 2.10 (1.58–2.78) 2.17 (1.62–2.91)
Above optimal cut points*
LDL-C 130 mg/dl 2.42 (1.83–3.20) 2.23 (1.68–2.98)
Systolic/diastolic BP
120/80 mm Hg
1.62 (1.21–2.16) 1.52 (1.12–2.06)
BMI 25 kg/m2 1.81 (1.38–2.38) 1.62 (1.21–2.17)
HDL-C 40 mg/dl 1.46 (1.02–2.08) 1.01 (0.69–1.49)
Glucose 110 mg/dl 3.19 (1.29–7.88) 3.04 (1.20–7.68)
Below optimal for HDL-C. †Models for: age adjusted for race, gender, and site; race adjusted for
ge, gender, and site; gender adjusted for age, race, and site; all other variables adjusted for age,
ace, gender, and site. ‡Simultaneously adjusted for age, race, gender, site, and all other risk
actors listed in Table 5.
BP  blood pressure; other abbreviations as in Tables 2 and 3.n white and African-American women). CThe higher prevalence in men versus women was consis-
ent with previous studies of widely varying ages (13,22–26).
s in most other studies, we found that CAC was more
revalent in white versus African-American men (22,24,26–
8,41), despite general findings of higher CVD morbidity
nd mortality among African Americans (42). Only 2
tudies found equal or higher CAC prevalence in African
mericans versus whites (43,44); both included older par-
icipants and had smaller samples with less geographic
ariation than in the CARDIA study. Importantly, our
ndings provide new evidence that, at least in men, differ-
ntial trends by race in CAC prevalence begin early in
dulthood. The lack of a significant race difference among
omen was probably the result of their lower CAC preva-
ence at this age, which is not surprising given that CVD
evelops later in women. Our findings in young men
upport the contention that race differences in CAC are not
ue to survival bias as has been suggested based on studies
f older adults (24).
Only 2 other young adult studies reported cross-sectional
elationships between CAC and established risk factors, and
ust 1 study examined them prospectively. Greater levels of
DL-C, triglycerides, systolic BP, and BMI were associated
ith CAC in 630 39- to 45-year-old male and female,
ultiethnic Army personnel, but LDL-C was the only
ndependent CAC correlate (23). Greater systolic BP, BMI,
nd LDL-C, and lower HDL-C in 384 white men and
omen ages 20 to 34 years were associated with subsequent
AC at ages 29 to 37 years, but only diastolic BP, BMI,
nd the ratio of total cholesterol to HDL cholesterol
redicted CAC independently of other risk factors (13).
ore risk factors may have been associated independently
ith CAC in the CARDIA study than in other studies
ecause of the larger sample and greater power. The longer
ollow-up in the CARDIA study also may explain differ-
nces, particularly for smoking, given the long incubation
eriod for CVD. Unlike previous studies, BMI was not
ndependently associated with CAC in the CARDIA
tudy. High BMI values are associated with greater noise
n CT scans that may be mistakenly read as CAC (39).
he CARDIA study scanning and reading protocols
ere designed to reduce noise effects, but other studies
ay have failed to do so. We observed an association with
aseline BMI before adjusting for other risk factors,
uggesting that BMI may influence subsequent CAC
hrough its effect on other risk factors.
Our finding that 15-year change in risk factor levels did
ot predict CAC independently of baseline levels may be
xplained by several factors. Secular declines in risk factors,
articularly smoking and LDL-C, may have diminished
AC and year 15 risk factor associations even though levels
n the CARDIA study worsened in part because of aging.
lternatively, baseline levels may have captured long-term
xposure, including the years before baseline, better than
ear 15 levels, as suggested by the lack of difference in
-statistics for baseline versus average 15-year levels but a
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May 22, 2007:2013–20 Early Adult Risk Factors and Coronary Calciumigher C-statistic for average 15-year versus year 15 levels.
ystolic BP did not track as well as other risk factors among
en and may explain why both baseline and 15-year change
n systolic BP levels were predictive of CAC. In addition,
xposure duration to the higher year 15 level may have been
nsufficient to affect CAC levels. Treatment of risk factors
uring follow-up may have masked an association with year
5 levels, but we found similar results after adjustment for
edication use at year 15.
tudy limitations. The CARDIA study, with comparable
easures over a relatively long follow-up, has many
trengths. Its large, ethnically and socioeconomically diverse
ample increases the generalizability of our findings. How-
ver, those participants who had versus those who did not
ave a CT scan were at baseline older, had a higher LDL-C
ut a lower BMI, and were less likely to smoke cigarettes.
hus, CAC prevalence estimates could have been biased
oth upward and downward because of attrition, but the
ffects of nonresponse bias on risk factor associations
ppeared to be minimal. This study used a conservative
T reading protocol, which may have underestimated
AC. Additionally, participants with very high body
eight (300 to 330 lbs) were ineligible for CT; this
MI truncation is also conservative and may explain why
ear 15 BMI was not a correlate of CAC. Finally, the low
revalence of CAC, especially among women, decreased
tatistical power to detect associations, and risk factors
ay be more strongly related to CAC with longer
ollow-up.
onclusions
isk factor levels in 18- to 30-year-old young adults
redicted calcification of plaque in coronary arteries at
ges 33 to 45 years better than concurrent levels, equally
ell as average 15-year levels, and regardless of 15-year
hange in levels. Thus, early adult levels of modifiable
VD risk factors, albeit relatively low, may be more
nformative than generally recognized by young adults
nd their clinicians. Young adults with above-optimal
isk factor levels at baseline, who were 2 to 3 times as
ikely to have CAC, and those with family history of
VD, which predicted CAC independently of estab-
ished risk factors in the CARDIA study (45), could be
argeted for preventive efforts. Waiting until modifiable
isk factor levels reach clinical guideline thresholds to
revent CVD may not be desirable because plaque
alcification is already underway and appears to be
ccelerating by ages 40 to 45 years. Earlier risk assess-
ent and efforts to encourage young adults to achieve and
aintain optimal levels may be needed to prevent or
elay coronary calcification, which has been shown to
redict subsequent coronary heart disease (16 –21).eprint requests and correspondence: Dr. Catherine M. Loria,
ational Heart, Lung, and Blood Institute, Division of Prevention
nd Population Sciences, 6701 Rockledge Drive, Room 10116,
ethesda, Maryland 20892-7936. E-mail: loriac@mail.nih.gov.
EFERENCES
1. Disparities in screening for and awareness of high blood cholesterol—
United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005;
54:117–9.
2. McGill HC Jr., McMahan CA, Zieske AW, et al. Associations of
coronary heart disease risk factors with the intermediate lesion of
atherosclerosis in youth. The Pathobiological Determinants of Ath-
erosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb
Vasc Biol 2000;20:1998–2004.
3. Daviglus ML, Stamler J, Pirzada A, et al. Favorable cardiovascular risk
profile in young women and long-term risk of cardiovascular and
all-cause mortality. JAMA 2004;292:1588–92.
4. Daviglus ML, Liu K, Pirzada A, et al. Favorable cardiovascular risk
profile in middle age and health-related quality of life in older age.
Arch Intern Med 2003;163:2460–8.
5. Daviglus ML, Liu K, Yan LL, et al. Body mass index in middle age
and health-related quality of life in older age: the Chicago Heart
Association Detection Project in Industry study. Arch Intern Med
2003;163:2448–55.
6. Daviglus ML, Liu K, Yan LL, et al. Relation of body mass index in
young adulthood and middle age to Medicare expenditures in older
age. JAMA 2004;292:2743–9.
7. Daviglus ML, Liu K, Pirzada A, et al. Cardiovascular risk profile
earlier in life and Medicare costs in the last year of life. Arch Intern
Med 2005;165:1028–34.
8. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men
and subsequent cardiovascular disease. N Engl J Med 1993;328:313–8.
9. Stamler J, Daviglus ML, Garside DB, et al. Relationship of baseline
serum cholesterol levels in 3 large cohorts of younger men to long-term
coronary, cardiovascular, and all-cause mortality and to longevity.
JAMA 2000;284:311–8.
0. McCarron P, Smith GD, Okasha M, McEwen J. Blood pressure in
young adulthood and mortality from cardiovascular disease. Lancet
2000;355:1430–1.
1. Miura K, Daviglus ML, Dyer AR, et al. Relationship of blood pressure
to 25-year mortality due to coronary heart disease, cardiovascular
diseases, and all causes in young adult men: the Chicago Heart
Association Detection Project in Industry. Arch Intern Med 2001;
161:1501–8.
2. McCarron P, Smith GD, Okasha M, McEwen J. Smoking in
adolescence and young adulthood and mortality in later life: prospec-
tive observational study. J Epidemiol Community Health 2001;55:
334–5.
3. Mahoney LT, Burns TL, Stanford W, et al. Coronary risk factors
measured in childhood and young adult life are associated with
coronary artery calcification in young adults: the Muscatine Study.
J Am Coll Cardiol 1996;27:277–84.
4. Bild DE, Folsom AR, Lowe LP, et al. Prevalence and correlates of
coronary calcification in black and white young adults: the Coronary
Artery Risk Development in Young Adults (CARDIA) study. Arte-
rioscler Thromb Vasc Biol 2001;21:852–7.
5. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS.
Coronary artery calcium area by electron-beam computed tomography
and coronary atherosclerotic plaque area. A histopathologic correlative
study. Circulation 1995;92:2157–62.
6. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron
beam computed tomography of the coronary arteries. 19-month
follow-up of 1173 asymptomatic subjects. Circulation 1996;93:
1951–3.
7. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD.
Prediction of coronary events with electron beam computed tomogra-
phy. J Am Coll Cardiol 2000;36:1253–60.
8. Secci A, Wong N, Tang W, Wang S, Doherty T, Detrano R. Electron
beam computed tomographic coronary calcium as a predictor of
coronary events: comparison of two protocols. Circulation 1997;96:
1122–9.
12
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
2020 Loria et al. JACC Vol. 49, No. 20, 2007
Early Adult Risk Factors and Coronary Calcium May 22, 2007:2013–209. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does
not accurately predict near-term future coronary events in high-risk
adults. Circulation 1999;99:2633–8.
0. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin
JM. Coronary artery calcium evaluation by electron beam computed
tomography and its relation to new cardiovascular events. Am J
Cardiol 2000;86:495–8.
1. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at
increased risk of first unheralded acute myocardial infarction by
electron-beam computed tomography. Circulation 2000;101:850–5.
2. Lee TC, O’Malley PG, Feuerstein I, Taylor AJ. The prevalence and
severity of coronary artery calcification on coronary artery computed
tomography in black and white subjects. J Am Coll Cardiol 2003;41:
39–44.
3. Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O’Malley
PG. Do conventional risk factors predict subclinical coronary artery
disease? Results from the Prospective Army Coronary Calcium
Project. Am Heart J 2001;141:463–8.
4. Newman AB, Naydeck BL, Whittle J, Sutton-Tyrrell K, Edmundow-
icz D, Kuller LH. Racial differences in coronary artery calcification in
older adults. Arterioscler Thromb Vasc Biol 2002;22:424–30.
5. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT.
Age and gender distributions of coronary artery calcium detected by
electron beam tomography in 35,246 adults. Am J Cardiol 2001;87:
1335–9.
6. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary
calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).
Circulation 2005;111:1313–20.
7. Budoff MJ, Yang TP, Shavelle RM, Lamont DH, Brundage BH.
Ethnic differences in coronary atherosclerosis. J Am Coll Cardiol
2002;39:408–12.
8. Doherty TM, Tang W, Detrano RC. Racial differences in the
significance of coronary calcium in asymptomatic black and white
subjects with coronary risk factors. J Am Coll Cardiol 1999;34:787–94.
9. Tang W, Detrano RC, Brezden OS, et al. Racial differences in
coronary calcium prevalence among high-risk adults. Am J Cardiol
1995;75:1088–91.
0. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study
design, recruitment, and some characteristics of the examined subjects.
J Clin Epidemiol 1988;41:1105–16.
1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concen-
tration of low-density lipoprotein cholesterol in plasma, without use of
the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
2. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque
measurement with cardiac CT in population-based studies: standard-
ized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and
Coronary Artery Risk Development in Young Adults (CARDIA)
study. Radiology 2005;234:35–43.3. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M
Jr., Detrano R. Quantification of coronary artery calcium using
ultrafast computed tomography. J Am Coll Cardiol 1990;15:827–32.
4. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas
under two or more correlated receiver operating characteristic curves: a
nonparametric approach. Biometrics 1988;44:837–45.
5. The National Cholesterol Education Program Expert Panel on De-
tection, Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III). Third Report of the National
Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults
(Adult Treatment Panel III) final report. Circulation 2002;106:3143–
421.
6. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension 2003;42:1206–52.
7. Wong ND, Kouwabunpat D, Vo AN, et al. Coronary calcium and
atherosclerosis by ultrafast computed tomography in asymptomatic
men and women: relation to age and risk factors. Am Heart J
1994;127:422–30.
8. Sekikawa A, Ueshima H, Zaky WR, et al. Much lower prevalence of
coronary calcium detected by electron-beam computed tomography
among men aged 40–49 in Japan than in the US, despite a less
favorable profile of major risk factors. Int J Epidemiol 2005;34:173–9.
9. Hall EF. Commentary: use of EBCT in epidemiological studies: the
effect of noise and body size on coronary calcium scores. Int J
Epidemiol 2005;34:179–80.
0. Bielak LF, Kaufmann RB, Moll PP, McCollough CH, Schwartz RS,
Sheedy PF. Small lesions in the heart identified at electron beam CT:
calcification or noise? Radiology 1994;192:631–6.
1. Tang W, Detrano RC, Brezden OS, et al. Racial differences in
coronary calcium prevalence among high-risk adults. Am J Cardiol
1995;75:1088–91.
2. Cooper R, Cutler J, Svigne-Nickens P, et al. Trends and disparities in
coronary heart disease, stroke, and other cardiovascular diseases in the
United States: findings of the national conference on cardiovascular
disease prevention. Circulation 2000;102:3137–47.
3. Jain T, Peshock R, McGuire DK, et al. African Americans and
Caucasians have a similar prevalence of coronary calcium in the Dallas
Heart Study. J Am Coll Cardiol 2004;44:1011–7.
4. Khurana C, Rosenbaum CG, Howard BV, et al. Coronary artery
calcification in black women and white women. Am Heart J 2003;
145:724–9.
5. Fornage M, Lopez DS, Roseman JM, Siscovick DS, Wong ND,
Boerwinkle E. Parental history of stroke and myocardial infarction
predicts coronary artery calcification: The Coronary Artery Risk
Development in Young Adults (CARDIA) study. Eur J Cardiovasc
Prev Rehabil 2004;11:421–6.
